Bloom HJ, Richardson WW (1957) Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11(3):359–377

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kollias J, Murphy CA, Elston CW, Ellis IO, Robertson JF, Blamey RW (1999) The prognosis of small primary breast cancers. Eur J Cancer 35(6):908–912

Article  CAS  PubMed  Google Scholar 

Smith JA 3rd, Gamez-Araujo JJ, Gallager HS, White EC, McBride CM (1977) Carcinoma of the breast: analysis of total lymph node involvement versus level of metastasis. Cancer 39(2):527–532

Article  PubMed  Google Scholar 

Takahashi H, Oshi M, Asaoka M, Yan L, Endo I, Takabe K (2020) Molecular biological features of nottingham histological grade 3 breast cancers. Ann Surg Oncol 27(11):4475–4485

Article  PubMed  PubMed Central  Google Scholar 

Qi R, Lin J, Chen S, Jiang J, Zhang X, Yao B et al (2022) Breast cancer prognosis and P-cadherin expression: systematic review and study-level meta-analysis. BMJ Support Palliat Care 12(e6):e893–e905

Article  PubMed  Google Scholar 

Lanigan F, McKiernan E, Brennan DJ, Hegarty S, Millikan RC, McBryan J et al (2009) Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer. Int J Cancer 124(9):2088–2097

Article  CAS  PubMed  Google Scholar 

Chavey C, Bibeau F, Gourgou-Bourgade S, Burlinchon S, Boissiere F, Laune D et al (2007) Oestrogen receptor negative breast cancers exhibit high cytokine content. Breast Cancer Res 9(1):R15

Article  PubMed  PubMed Central  Google Scholar 

Figueroa JD, Flanders KC, Garcia-Closas M, Anderson WF, Yang XR, Matsuno RK et al (2010) Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics. Breast Cancer Res Treat 121(3):727–735

Article  CAS  PubMed  Google Scholar 

McSherry EA, Donatello S, Hopkins AM, McDonnell S (2007) Molecular basis of invasion in breast cancer. Cell Mol Life Sci 64(24):3201–3218

Article  CAS  PubMed  PubMed Central  Google Scholar 

Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19(5):403–10

Article  CAS  PubMed  Google Scholar 

Samaratunga H, Egevad L, Yaxley J, Perry-Keene J, Le Fevre I, Kench J et al (2024) Gleason score 3+3=6 prostatic adenocarcinoma is not benign and the current debate is unhelpful to clinicians and patients. Pathology 56(1):33–38

CAS  PubMed  Google Scholar 

van Dooijeweert C, van Diest PJ, Ellis IO (2022) Grading of invasive breast carcinoma: the way forward. Virchows Arch 480(1):33–43

Article  PubMed  Google Scholar 

Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN (2004) Breast carcinoma in men: a population-based study. Cancer 101(1):51–57

Article  PubMed  Google Scholar 

Kornegoor R, Verschuur-Maes AH, Buerger H, Hogenes MC, de Bruin PC, Oudejans JJ et al (2012) Immunophenotyping of male breast cancer. Histopathology 61(6):1145–1155

Article  PubMed  Google Scholar 

Lautrup MD, Thorup SS, Jensen V, Bokmand S, Haugaard K, Hoejris I et al (2018) Male breast cancer: a nation-wide population-based comparison with female breast cancer. Acta Oncol 57(5):613–621

Article  PubMed  Google Scholar 

Jylling AMB, Jensen V, Lelkaitis G, Christiansen P, Nielsen SS, Lautrup MD (2020) Male breast cancer: clinicopathological characterization of a National Danish cohort 1980–2009. Breast Cancer 27(4):683–695

Article  PubMed  Google Scholar 

Nilsson C, Johansson I, Ahlin C, Thorstenson S, Amini RM, Holmqvist M et al (2013) Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact. Acta Oncol 52(1):102–109

Article  PubMed  Google Scholar 

Bhardwaj PV, Gupta S, Elyash A, Teplinsky E (2024) Male breast cancer: a review on diagnosis, treatment, and survivorship. Curr Oncol Rep. https://doi.org/10.1007/s11912-023-01489-z

Article  PubMed  Google Scholar 

Flannery MA, Culakova E, Canin BE, Peppone L, Ramsdale E, Mohile SG (2021) Understanding treatment tolerability in older adults with cancer. J Clin Oncol 39(19):2150–2163

Article  PubMed  PubMed Central  Google Scholar 

Solomayer EF, Diel IJ, Meyberg GC, Gollan C, Bastert G (2000) Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat 59(3):271–278

Article  CAS  PubMed  Google Scholar 

Leone J, Hassett MJ, Freedman R, Tolaney S, Graham N, Tayob N et al (2023) Mortality risks over 20 years in men with stage I-III hormone receptor-positive breast cancer. Cancer Res. https://doi.org/10.1158/1538-7445.SABCS22-PD6-08

Article  Google Scholar 

Johansson I, Killander F, Linderholm B, Hedenfalk I (2014) Molecular profiling of male breast cancer—lost in translation? Int J Biochem Cell Biol 53:526–535

Article  CAS  PubMed  Google Scholar 

Macdonald G, Paltiel C, Olivotto IA, Tyldesley S (2005) A comparative analysis of radiotherapy use and patient outcome in males and females with breast cancer. Ann Oncol 16(9):1442–1448

Article  CAS  PubMed  Google Scholar 

Cloyd JM, Hernandez-Boussard T, Wapnir IL (2013) Outcomes of partial mastectomy in male breast cancer patients: analysis of SEER, 1983–2009. Ann Surg Oncol 20(5):1545–1550

Article  PubMed  Google Scholar 

Madden NA, Macdonald OK, Call JA, Schomas DA, Lee CM, Patel S (2016) Radiotherapy and male breast cancer: a population-based registry analysis. Am J Clin Oncol 39(5):458–462

Article  CAS  PubMed  Google Scholar 

Li N, Wang X, Zhang H, Wang H (2018) Young male breast cancer, a small crowd, the survival, and prognosis? A population-based study. Medicine (Baltimore) 97(40):e12686

Article  PubMed  Google Scholar 

Wei JL, Zhang JX, Fu DY (2018) Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study. World J Surg Oncol 16(1):236

Article  PubMed  PubMed Central  Google Scholar 

Leone J, Freedman RA, Lin NU, Tolaney SM, Vallejo CT, Leone BA et al (2021) Tumor subtypes and survival in male breast cancer. Breast Cancer Res Treat 188(3):695–702

Article  CAS  PubMed  Google Scholar 

Pan H, Zhang K, Wang M, Ling L, Wang S, Zhou W (2020) The effect of chemotherapy on survival in patients with nonmetastatic male breast cancer: a population-based observational study. Cancer 126(Suppl 16):3830–3836

Article  CAS  PubMed  Google Scholar 

Sun W, Cheng M, Zhou H, Huang W, Qiu Z (2019) Nomogram predicting cause-specific mortality in nonmetastatic male breast cancer: a competing risk analysis. J Cancer 10(3):583–593

Article  PubMed  PubMed Central  Google Scholar 

Wang Y, Chen K, Yang Y, Tan L, Chen L, Zhu L et al (2019) Incidence and survival outcomes of early male breast cancer: a population-based comparison with early female breast cancer. Ann Transl Med 7(20):536

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han Y, Wang J, Wang Z, Xu B (2021) Sex-based heterogeneity in the clinicopathological characteristics and prognosis of breast cancer: a population-based analysis. Front Oncol 11:642450

Article